NCT01406301View on ClinicalTrials.gov

Fondaparinux EU-RMP (Adherence)

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Acute Coronary Syndrome
Interventions
DRUG

fondaparinux

fondaparinux

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY